Navigating Rising Medicare Costs: A Regeneron Pharmaceuticals Employee’s Guide

Healthcare Provider Update: Healthcare Provider for Regeneron Pharmaceuticals: Regeneron Pharmaceuticals primarily collaborates with a range of healthcare providers, including hospitals, specialty clinics, and other medical organizations that focus on treating conditions related to its drug portfolio. The company often works with health systems, managed care organizations, and practices that specialize in therapeutic areas such as oncology, ophthalmology, and immunology, with notable partnerships aimed at advancing clinical research and access to its innovative treatments. Potential Healthcare Cost Increases in 2026: As we approach 2026, healthcare costs are projected to surge significantly, largely due to the anticipated expiration of enhanced federal subsidies under the Affordable Care Act and continued inflation in medical expenses. Reports suggest that some states may face premium hikes exceeding 60%, potentially increasing out-of-pocket costs for enrollees by up to 75%. This turbulence stems from a convergence of higher medical costs, substantial drug spending, and a regulatory landscape that pressures insurers to increase rates. Without timely congressional action to renew premium tax credits, many consumers could be priced out of affordable healthcare coverage. Click here to learn more

“In light of projected Medicare Part B premium increases, Regeneron Pharmaceuticals employees should proactively adjust their retirement income projections and consult with a financial advisor to address rising health care expenses.” – Michael Corgiat, a representative of The Retirement Group, a division of Wealth Enhancement.

“In anticipation of significant Medicare Part B premium hikes, Regeneron Pharmaceuticals employees would benefit from integrating health care cost projections into their retirement plans and seeking guidance from professional advisors on potential relief strategies.” – Brent Wolf, a representative of The Retirement Group, a division of Wealth Enhancement.

In this article we will discuss:

1. The upcoming Medicare Part B premium increase and its impact on retirement budgets.

2. How Medicare Part B is funded and how COLA adjustments compare to premium hikes.

3. Strategic planning tips to help Regeneron Pharmaceuticals retirees manage rising health care costs.

There will soon be a significant shift in Medicare expenses that could affect your retirement budget. According to the 2025 Medicare Trustees Report, the average Part B premium will jump by 11.6%—rising from $185 in 2025 to $206.50 in 2026 ¹ —outpacing most Social Security cost of living adjustments (COLA) over the last decade. Regeneron Pharmaceuticals employees should begin factoring this increase into their long-term financial plans.

Benefit Structure for Medicare Part B

Outpatient and preventative care are covered under Part B, including:

• - Cancer screenings, diagnostic procedures, and doctor visits

• - Durable medical equipment and mental health counseling

• - Prescription medications for outpatients and ambulance transportation

• - Skilled nursing services and home health care

In 2025, beneficiaries must pay a $185 monthly premium, a $257 annual deductible, and a 20% co-insurance on most services—important information for any Regeneron Pharmaceuticals retiree’s annual budget.

History of Premiums (2015–2025)

Estimated Premiums (2026–2034)

The Funding Mechanisms

There are two primary sources of funding for Medicare Part B:

1. 75% from general U.S. Treasury revenues

2. 25% from premiums paid by beneficiaries

Premium income reached $139.8 billion in 2024, ²  with additional support from brand name drug fees and trust fund interest—details that Regeneron Pharmaceuticals retirees may find crucial when reviewing their future health care funding.

Cost of Living Adjustments vs. Premium Increases

In 2026, the “hold harmless” provision that protects most Social Security benefits from Part B hikes may not apply. The anticipated 2.5% Social Security COLA—roughly $50 per month—still falls short of the $21.50 premium increase. Only recipients with monthly benefits under $800 will see any net gain, so Regeneron Pharmaceuticals employees relying on Social Security should plan for most of their increase to be offset.

Strategic Planning Tips

To manage rising health care costs, Regeneron Pharmaceuticals employees should consider the following proactive steps:

• Forecast Health Care Inflation:  Incorporate rising out-of-pocket costs and premiums into your annual budgeting.

• Compare Plans Online:  Use the official Medicare Plan Finder to evaluate alternatives beyond agent recommendations.

• Manage IRMAA Exposures:  Employ tax-sensitive strategies—such as income smoothing withdrawals—to help limit future surcharges.

• Explore Local Tax Relief:  Research state and municipal programs offering property tax exemptions or rebates for seniors.

• Stress-Test Your Retirement Portfolio:  Model health care inflation scenarios over multiple decades and adjust allocations to safeguard purchasing power.

Extended Consequences

By 2034, annual Part B costs alone could top $3,000–$4,000 if current trends persist—one of the fastest rising expense categories for retirement households. Regeneron Pharmaceuticals retirees who plan early can navigate budgetary shocks to help maintain their lifestyle goals.

According to Wealth Enhancement’s Patrick Ray, this premium surge ranks among the steepest retirement cost increases, and prudent investors must factor health care inflation into their retirement forecasts to mitigate unwelcome surprises.

Featured Video

Articles you may find interesting:

Sources:

1. USA Today. ' Social Security 2026 COLA estimated at 2.7%, but much of it will go to Medicare Part B ,' by Medora Lee. 17 July 2025.

2. Boards of Trustees of the Federal Hospital Insurance and Federal Supplementary Medical Insurance Trust Funds. ' 2025 Annual Report of the Boards of Trustees of the Federal Hospital Insurance and Federal Supplementary Medical Insurance Trust Funds ,' U.S. Department of Health and Human Services, 18 June 2025. 

Other Resources:

1. Kaiser Family Foundation. “ FAQs on Medicare Financing and Trust Fund Solvency .” Kaiser Family Foundation, 15 June 2024.

3. Urban Institute. “ Applying a Premium Cap in Medicare Part B and Part D .” Urban Institute, Mar. 2023.

4. “ Social Security’s 2026 COLA: Recipients Could Get More Money Next Year .” LiveNOW from FOX, 15 June 2025.

5. Kiplinger Staff. “ Medicare Premiums 2026: Projected IRMAA Brackets and Surcharges for Parts B and D .” Kiplinger, 26 June 2025.